JAMA Editor’s Summary

Fluvoxamine for Outpatients With Mild to Moderate COVID-19, Accuracy of Stroke Risk Prediction Models, Organization and Performance of US Health Systems, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 24/31, 2023, issue. Related Content:

January 24, 2023

Listen on your favorite player Take me to this show’s page

Newer →

Aflibercept to Prevent Vision Complications of Diabetic Retinopathy, History of Adverse Pregnancy Outcomes and CT-Identified Coronary Artery Disease, Review of Managing Menopausal Symptoms, and more

← Older

Loop Diuretics for Heart Failure, Oxygen Therapy Strategies for Children With Acute Hypoxemic Respiratory Failure, Review of Surgical Site Infection Prevention, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Fluvoxamine for Outpatients With Mild to Moderate COVID-19, Accuracy of Stroke Risk Prediction Models, Organization and Performance of US Health Systems, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 24/31, 2023, issue. Related Content: